Fast fOod Shops Significantly Impact Cardiovascular Karma - the FOSSICK IV Trial - Reddy M, Luque M, Ferrer Ferrer L, Koju R, Zaman MJ, Inspiron D, Caprnda.

Slides:



Advertisements
Similar presentations
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Advertisements

SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
1 China Rural Health Initiative – Sodium Reduction Study: the effects of a community-based sodium reduction program on 24hr urinary sodium and blood pressure.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
Slide Source LipidsOnline CO O C CH 3 COOCH CH 3 Cl CH 3 OC COOC 2 H 5 CH 3 Cl CH 3 OCH 2 CH 3 COOH CH 3 C Fenofibrate Clofibrate.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
The Prevalence of Male Hypotestosteronism in Type 2 Diabetics in a Southwest Virginia Population Dr. Eric Hofmeister Dr. Christopher Bishop.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Healthy eating for middle-years Professor Tom Sanders Nutritional Sciences Division.
HDL Particles but not LDL Particles Predict Cardiovascular Disease Events in HIV Patients: Results from Strategies for Management of ART Study (SMART)
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
 High density lipoproteins (HDL) protect against cardiovascular disease  A novel mechanism for raising HDL levels is to inhibit a protein known as CETP.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Ramón Estruch, M.D., Ph.D., …and 18 others for PREDIMED study investigators Published:
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
Modern Management of Cholesterol in the High-Risk Patient.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.
ALCOHOL AND HEALTH Morten Grønbæk National Institute of Public Health Copenhagen, Denmark.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014.
Gabrielle Sherer Cardiovascular Risk Reduction Jeff Luckring MS, RD.
Prof K Srinath Reddy President Public Health Foundation of India & Professor of Cardiology All India Institute of Medical Sciences, New Delhi Prof K Srinath.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
 2010 Wellsource, Inc. All rights reserved. Polyunsaturated Fats and CHD Harvard Study 2010.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
National and subnational mortality effects of major metabolic risk factors and smoking in Iran: a comparative risk assessment Scientific Webinars Farzadfar.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
4S: Scandinavian Simvastatin Survival Study
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease (HOPE-3 trial) R4. 박은지 / PF. 정혜문 Salim Yusuf, M.B., B.S., D.Phil.,
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
SECONDARY PREVENTION IN HEART DISEASE CATHY QUICK AUBURN UNIVERSITY/AUBURN MONTGOMERY EBP III.
Date of download: 7/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fish Intake, Contaminants, and Human Health: Evaluating.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.
Metabolic Comorbidities of Young Children
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
ACCORD Design and Baseline Characteristics
Title slide.
by Sarah Steinmetz and Amber Brouillette
AIM HIGH Niacin plus Statin to prevent vascular events
HDL cholesterol and cardiovascular risk Epidemiological evidence
HDL cholesterol and cardiovascular risk
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
FATS- Familial Atherosclerosis Treatment Study
TNT: Baseline and final LDL cholesterol levels
اتجاهات أنماط المرض بين السكان. المراحل الأربع للتحول الوبائى.
Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial Dr Ajay K Gupta International Centre for Circulatory.
Section 7: Aggressive vs moderate approach to lipid lowering
Level of risk factor control in the overall sample and by gender
Goals & Guidelines A summary of international guidelines for CHD
Baseline Characteristics, Blood Pressures, and Laboratory Values
Section II: Lipid management
PROSPER: trial design                                                                                                                                                                 
University College London
Presentation transcript:

Fast fOod Shops Significantly Impact Cardiovascular Karma - the FOSSICK IV Trial - Reddy M, Luque M, Ferrer Ferrer L, Koju R, Zaman MJ, Inspiron D, Caprnda M, Leosdottir M, Kengne AP. Circulation 2007;45:123-9 FOSS CK

Background Observational and case-control studies indicate a unfavorable CVD risk factor profile in individuals with high fast-food consumption compared to the general population (1,2) No randomized trial has yet been conducted to evaluate the relationship between fast-food exposure and cardiovascular disease or CVD risk factors. 1.Kengne AP et al. FOSSICK I Study. Lancet Leong T et al. FACE-IT Study. NEJM 2006 FOSS CK

Background Previous studies have shown a strong relationship between cholesterol and blood pressure levels and CVD risk Lowering LDL cholesterol by 40 mg/dl decreases CHD mortality by 20% and stroke mortality by 17%. FOSS CK

Study question Is decreased use of fast food shops associated with improved cardiovascular risk profile? FOSS CK Fast food  LDL  CVD risk

Design Randomized clinical trial Single-blinded –Subjects not blinded –Investigators not blinded –Analysers blinded Intention-to-treat analysis FOSS CK

Exposure Use of fast food shops to purchase a meal Definitions: –Use: Consumption of a meal (breakfast, lunch or dinner) –Fast food shops: Listed for the subjects (McDonalds, KFC, TacoBell etc....) FOSS CK

Standard deviation Minimum detectable alternative Number of subjects needed LDL cholesterol 15 mg/dl [0.40 mmol/l] 10 mg/dl [0.25 mmol/l] Total cholesterol 25 mg/dl [0.60 mmol/l] 10 mg/dl [0.25 mmol/l] α = 5%, β = 10%, power 90% Sample size determination FOSS CK

Chicago Sear’s Tower (n=10 000) Subjects expressing interest in participation (n=1 300) Informed consent & baseline screening (n=510) 30 subjects excluded after lipid/glucose analysis FOSS CK RANDOMIZATION Exclusion / not interested (n=790) Study design & protocol I

Control group (n=240) Unchanged dietary pattern Intervention group (n=240) Elimination of use of fast food shops Study design & protocol II FOSS CK RANDOMIZATION Follow up: 3 months Final study visit

Baseline examination Questionnaires: –Baseline information plus physical activity – Fast food consumption –Food Frequency Questionnaire Physical examination Blood sampling FOSS CK

Intervention Information at baseline –Small group info meetings Support: –Telephone calls / interviews / counselling –SMS text messages –Newsletters Measurements of compliance FOSS CK

Outcomes Change in: –LDL (primary outcome) –Total cholesterol –TG –HDL –FPG –Blood pressure –BMI –WHR/waist circumference FOSS CK

Control groupIntervention group n=235n=232 Age (years)39.3 ± ± 7.1 % females47%45% % caucasian73%71% Mean ys of education8.3 ys8.1 ys % smokers23%20% Income (US$ pr year) US$ US$ Average PA (mean score 1-4) Mean energy intake (kcal/day) Weekly use of FF shops Mean alcohol intake (g/day) Mean LDL (mmol/l) BMI Selected baseline characteristics FOSS CK

Results presentation Control group Interven tion group Sign. TC LDL HDL TG FPG SBP DBP BMI WHR Waist c. FOSS CK

Budget SOURCES OF $$$: 1.NHLBI 2.FOOD INDUSTRY (healthy fast food shops, grocery stores) 3.FOUNDATIONS (e.g. Fogarty Foundation, Wellcome Trust) PROJECTED BUDGET: $3 MILLION FOSS CK

Discussion Study strengths –First study of its kind –Generalisability Possible limitations of the study –Effect of the chosen method of intervention –Measurement of the exposure/compliance FOSS CK

Thank you!! FOSS CK

References Dariush M et al. Trans Fatty Acids and Cardiovascular Disease. N Engl J Med 2006; 354: AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: National Cholesterol Education Program: National Heart, Lung, and Blood Institute National Institutes of Health NIH Publication No September 2002 FOSS CK